Loading
Clarity Pharmaceuticals Ltd Stock: price and insider trades · Australia
Clarity Pharmaceuticals Ltd: what insiders have been doing
This page follows insider dealings at Clarity Pharmaceuticals Ltd as filed with ASX. From 20 October 2025 to 20 October 2026, the disclosure feed for Clarity Pharmaceuticals Ltd logged 20 filings by 7 insiders.
All open-market trades in the period are sales: 1 sale worth €671k, by 1 insider, with no purchase on record. The largest single trade was a sale of €671k by Michelle Parker, published on 22 April 2026, equal to 0.11% of the market capitalisation.
Across the 1,613 companies tracked on its exchange, the median is 4 filings; at 20 filings, this issuer sits above that mark. Since 2026, the database holds no purchases and 1 sale by insiders of the company.
Between a trade and the moment it shows up on ASX, the median delay is 2 days. That lag is the time during which only the insider knows about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
Source: insider filings from ASX. Past trades are no guide to future returns.
Insider Decl.
20
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€671,268
1 ops. · all time
Who traded when
BuySaleMichelle Parker1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended June 2025 · cache
A$1.79
Analyst consensus
4 analysts1.00/5
A$5.60Target A$7.20(+302%)A$8.40
Income statement
EBITDA-A$78.4M
Net income-A$64.3M0.0% margin
Valuation
PER (forward)-6.7x
P/Book3.6x
Beta1.18
Balance sheet & cash
Market capA$667.8M
Free Cash Flow-A$55M
Profitability & ownership
ROE-77.5%
ROA-45.1%
% insiders21.1%
% institutions26.3%
Last declaration on 20 October 2026
Declarations20 total
●
Unknown Substantial Holder
0ASX
ShareASXISIN AU0000165375ASX:2924-03150750-2A1705155
●
Unknown Substantial Holder
0ASX
ShareASXISIN AU0000165375ASX:2924-03144481-2A1701842
ShareASXISIN AU0000165375ASX:2924-03139560-2A1699113
ShareASXASX:2924-03138250-2A1698447
ShareASXASX:2924-03125272-2A1691559
ShareASXISIN AU0000165375ASX:2924-03120538-2A1689195
ShareASXASX:2924-03119112-2A1688502
ShareASXISIN AU0000165375ASX:2924-03118735-2A1688143
ShareASXISIN AU0000165375ASX:2924-03118291-2A1687797
ShareASXASX:2924-03116879-2A1687054
ShareASXISIN AU0000165375ASX:2924-03116081-2A1686779
ShareASXISIN AU0000165375ASX:2924-03111769-2A1684827
ShareASXISIN AU0000165375ASX:2924-03108861-2A1683333
ShareASXISIN AU0000165375ASX:2924-03108340-2A1682965
ShareASXASX:2924-03105952-2A1680862
ShareASXASX:2924-03104021-2A1679456
ShareASXASX:2924-03102590-2A1678536
ShareASXISIN AU0000165375ASX:2924-03101654-2A1678110
ShareASXISIN AU0000165375ASX:2924-03101252-2A1677899
360,896 shares@ A$3.05550.11% mcap100.0% of flowShareASXASX:2924-03081425-2A1667765
20 of 20 declarations
About Clarity Pharmaceuticals Ltd
Clarity Pharmaceuticals Ltd is a company focused on developing innovative treatments for serious diseases. It is listed on the Australian Securities Exchange (XASX).